Tumor-stroma ratio is an independent predictor for survival in early cervical carcinoma.

[1]  D. Jeong,et al.  Expression of Secreted Protein Acidic and Rich in Cysteine in the Stroma of a Colorectal Carcinoma is Associated With Patient Prognosis , 2013, Annals of coloproctology.

[2]  B F Warren,et al.  The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  G. Phillips,et al.  The impact of close surgical margins after radical hysterectomy for early-stage cervical cancer. , 2013, Gynecologic oncology.

[4]  Houqiang Liu,et al.  Tumor-Stroma Ratio Is an Independent Predictor for Survival in Esophageal Squamous Cell Carcinoma , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[5]  Jeong Eon Lee,et al.  The prognostic significance of tumor-associated stroma in invasive breast carcinoma , 2012, Tumor Biology.

[6]  J. Nicklin,et al.  Analysis of Prognostic Variables, Development of Predictive Models, and Stratification of Risk Groups in Surgically Treated FIGO Early-Stage (IA–IIA) Carcinoma Cervix , 2012, International Journal of Gynecologic Cancer.

[7]  Š. Smrkolj,et al.  Clinical outcome of patients with FIGO stage IA2 squamous cell carcinoma of the uterine cervix. , 2012, Gynecologic oncology.

[8]  Thomas Filleron,et al.  Human solid tumors contain high endothelial venules: association with T- and B-lymphocyte infiltration and favorable prognosis in breast cancer. , 2011, Cancer research.

[9]  L. Stalpers,et al.  Prognostic model for survival in patients with early stage cervical cancer , 2011, Cancer.

[10]  Hein Putter,et al.  Tumor–stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients , 2011, Breast Cancer Research and Treatment.

[11]  K. Edlund,et al.  Forkhead box F1 regulates tumor-promoting properties of cancer-associated fibroblasts in lung cancer. , 2010, Cancer research.

[12]  Jian-Hua Fu,et al.  Fibroblast Growth Factor Receptor 2–Positive Fibroblasts Provide a Suitable Microenvironment for Tumor Development and Progression in Esophageal Carcinoma , 2009, Clinical Cancer Research.

[13]  T. Kiyono,et al.  Molecular mechanisms of cervical carcinogenesis by high‐risk human papillomaviruses: novel functions of E6 and E7 oncoproteins , 2009, Reviews in medical virology.

[14]  F. Pépin,et al.  Stromal gene expression predicts clinical outcome in breast cancer , 2008, Nature Medicine.

[15]  C. Iacobuzio-Donahue,et al.  Peritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  I. Fentiman,et al.  Different patterns of inflammation and prognosis in invasive carcinoma of the breast , 2006, Histopathology.

[17]  N. Singh,et al.  Histopathologic parameters of prognosis in cervical cancer – a review , 2004, International Journal of Gynecologic Cancer.

[18]  E Helene Sage,et al.  Enhanced expression of SPARC/osteonectin in the tumor-associated stroma of non-small cell lung cancer is correlated with markers of hypoxia/acidity and with poor prognosis of patients. , 2003, Cancer research.

[19]  Olivier De Wever,et al.  Role of tissue stroma in cancer cell invasion , 2003, The Journal of pathology.

[20]  Mina J. Bissell,et al.  Putting tumours in context , 2001, Nature Reviews Cancer.

[21]  Elise C. Kohn,et al.  The microenvironment of the tumour–host interface , 2001, Nature.

[22]  Thomas Gm.  Adjuvant therapy after primary surgery for stage I-IIA carcinoma of the cervix. , 1996 .

[23]  G. Thomas.  Adjuvant therapy after primary surgery for stage I-IIA carcinoma of the cervix. , 1996, Journal of the National Cancer Institute. Monographs.

[24]  B. Sevin,et al.  Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. , 1990, Gynecologic oncology.